Mark Vachon - 22 Jun 2022 Form 4 Insider Report for bluebird bio, Inc. (BLUE)

Reporting relationship: Director
Issuer ticker: BLUE
Reported as of: 22 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 Jun 2022, 18:09:22 UTC
Prior SEC filing: 16 Nov 2021
Next SEC filing: 20 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Jason F. Cole, Attorney-in-Fact

Key filing fact

Mark Vachon filed Form 4 for bluebird bio, Inc. (BLUE) on 23 Jun 2022.

Key facts

This page summarizes Mark Vachon's Form 4 filing for bluebird bio, Inc. (BLUE).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 23 Jun 2022, 18:09.

Change

Previous filing in this sequence was filed on 16 Nov 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BLUE transaction

Common Stock

Award

Transaction value: $0
Shares: +4,353
Change %: +44%
Price: $0.000000
Shares after: 14,251
Date: 22 Jun 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BLUE transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +7,000
Change %
Price: $0.000000
Shares after: 7,000
Date: 22 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,000
Exercise price: $4.46
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These restricted stock units for common stock vest 100% on the earlier of June 22, 2023 or the date of the next annual meeting of stockholders.

Footnote F2

This option vests 100% on the earlier of June 22, 2023 or the date of the next annual meeting of stockholders.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .